NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $178 | -70.4% | 253,113 | -5.0% | 0.00% | -100.0% |
| Q4 2022 | $602 | -99.9% | 266,340 | -1.1% | 0.00% | -50.0% |
| Q3 2022 | $862,000 | -16.3% | 269,340 | -0.6% | 0.00% | -33.3% |
| Q2 2022 | $1,030,000 | -29.5% | 271,100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,461,000 | -60.1% | 271,100 | 0.0% | 0.00% | -57.1% |
| Q4 2021 | $3,663,000 | -9.0% | 271,100 | +20.9% | 0.01% | -22.2% |
| Q3 2021 | $4,027,000 | +9.5% | 224,232 | +4.7% | 0.01% | +12.5% |
| Q2 2021 | $3,676,000 | -14.2% | 214,200 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $4,284,000 | +17.7% | 214,200 | +0.0% | 0.01% | +12.5% |
| Q4 2020 | $3,640,000 | +2.5% | 214,100 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $3,552,000 | -28.4% | 214,100 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $4,959,000 | +29.7% | 214,100 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $3,822,000 | -17.3% | 214,100 | 0.0% | 0.01% | +9.1% |
| Q4 2019 | $4,621,000 | +12.8% | 214,100 | -4.8% | 0.01% | +10.0% |
| Q3 2019 | $4,098,000 | -48.8% | 224,967 | +0.0% | 0.01% | -50.0% |
| Q2 2019 | $8,002,000 | +5.9% | 224,907 | +0.0% | 0.02% | +5.3% |
| Q1 2019 | $7,556,000 | +2.2% | 224,894 | +0.0% | 0.02% | -9.5% |
| Q4 2018 | $7,390,000 | -46.1% | 224,831 | +0.0% | 0.02% | -34.4% |
| Q3 2018 | $13,703,000 | +23.5% | 224,793 | -1.1% | 0.03% | +18.5% |
| Q2 2018 | $11,094,000 | -55.5% | 227,189 | -3.2% | 0.03% | -55.7% |
| Q1 2018 | $24,937,000 | +46.5% | 234,677 | -17.7% | 0.06% | +52.5% |
| Q4 2017 | $17,020,000 | +175.7% | 285,000 | +10.8% | 0.04% | +166.7% |
| Q3 2017 | $6,173,000 | +22.9% | 257,224 | +0.2% | 0.02% | +15.4% |
| Q2 2017 | $5,021,000 | -16.4% | 256,824 | +0.3% | 0.01% | -13.3% |
| Q1 2017 | $6,009,000 | +91.9% | 256,024 | +0.3% | 0.02% | +87.5% |
| Q4 2016 | $3,132,000 | -28.2% | 255,224 | +0.5% | 0.01% | -33.3% |
| Q3 2016 | $4,362,000 | +22.5% | 253,924 | +1.4% | 0.01% | +33.3% |
| Q2 2016 | $3,562,000 | +4.7% | 250,324 | +1.2% | 0.01% | 0.0% |
| Q1 2016 | $3,401,000 | -17.7% | 247,324 | +0.9% | 0.01% | -18.2% |
| Q4 2015 | $4,130,000 | +181.5% | 245,124 | +83.2% | 0.01% | +175.0% |
| Q3 2015 | $1,467,000 | +106.0% | 133,824 | +135.0% | 0.00% | +100.0% |
| Q2 2015 | $712,000 | – | 56,938 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |